Cholera Vaccines
Introduction to Cholera Vaccines
Cholera vaccines are biological preparations designed to protect against cholera, an acute diarrheal infection caused by ingestion of food or water contaminated with the bacterium Vibrio cholerae. Cholera can lead to severe dehydration and death if left untreated.
Key Points:
- Cholera vaccines are an important tool in cholera control, especially in endemic areas and during outbreaks.
- They are used alongside other preventive measures such as improved sanitation and access to clean water.
- The first cholera vaccine was developed in 1885 by Jaime Ferrán, a Spanish physician.
- Modern cholera vaccines are much safer and more effective than early versions.
- The World Health Organization (WHO) recommends the use of cholera vaccines in conjunction with other cholera prevention and control strategies.
Types of Cholera Vaccines
There are several types of cholera vaccines available, with oral vaccines being the most commonly used today:
1. Oral Cholera Vaccines (OCVs)
a. Dukoral (WC-rBS)
- Contains killed whole cells of V. cholerae O1 and recombinant cholera toxin B subunit
- Provides protection against V. cholerae O1
- Licensed for use in individuals 2 years and older
b. Shanchol, Euvichol, and Euvichol-Plus
- Contain killed whole cells of V. cholerae O1 and O139
- Do not contain the cholera toxin B subunit
- Licensed for use in individuals 1 year and older
c. Vaxchora
- Live attenuated single-dose vaccine
- Contains live attenuated V. cholerae O1 strain CVD 103-HgR
- Licensed in the United States for adults 18-64 years old traveling to cholera-affected areas
2. Injectable Cholera Vaccines
- Older type of cholera vaccine
- No longer recommended by WHO due to limited efficacy and short duration of protection
- Not commonly used today
Vaccine Efficacy
The efficacy of cholera vaccines varies depending on the type of vaccine and the population in which it's used.
Oral Cholera Vaccines (OCVs):
Dukoral (WC-rBS):
- Provides about 85% protection in the first 6 months after vaccination
- Protection drops to about 50-60% after 2 years
- May provide some cross-protection against enterotoxigenic Escherichia coli (ETEC)
Shanchol, Euvichol, and Euvichol-Plus:
- Provide about 65% protection in the first year after vaccination
- Protection remains around 50% in the second year
- Some studies suggest protection may last up to 5 years
Vaxchora:
- Provides 90% protection at 10 days post-vaccination
- Protection drops to about 80% at 3 months post-vaccination
Factors Affecting Efficacy:
- Age: Lower efficacy in young children
- HIV status: May be less effective in HIV-positive individuals
- Malnutrition: Can reduce vaccine efficacy
- Previous exposure to cholera: May enhance vaccine-induced immunity
Herd Immunity:
OCVs have shown to provide indirect protection to unvaccinated individuals in communities with high vaccination coverage, demonstrating a herd immunity effect.
Vaccination Schedule
The vaccination schedule varies depending on the type of cholera vaccine used:
Dukoral (WC-rBS):
- Adults and children ≥6 years: 2 doses given orally 1-6 weeks apart
- Children 2-5 years: 3 doses given orally 1-6 weeks apart
- Booster: After 2 years for adults and children ≥6 years, after 6 months for children 2-5 years
Shanchol, Euvichol, and Euvichol-Plus:
- All ages ≥1 year: 2 doses given orally 14 days apart
- Booster: After 2 years
Vaxchora:
- Single oral dose for adults 18-64 years
- Should be administered at least 10 days before potential exposure to cholera
Special Considerations:
- In outbreak settings, a single-dose strategy may be used with Shanchol or Euvichol to quickly provide short-term protection
- Pregnancy: OCVs are considered safe for pregnant women
- Immunocompromised individuals: OCVs are considered safe but may be less effective
Side Effects and Safety
Cholera vaccines are generally considered safe, with most side effects being mild and transient.
Common Side Effects:
- Gastrointestinal discomfort
- Abdominal pain
- Diarrhea
- Nausea
- Vomiting (rare)
- Headache
- Fever (low-grade)
Rare Side Effects:
- Severe allergic reactions (anaphylaxis): Extremely rare
- Guillain-Barré syndrome: No causal relationship established, but temporally associated cases have been reported
Safety Considerations:
- OCVs do not contain live bacteria and cannot cause cholera
- Safe for use in HIV-positive individuals, though efficacy may be reduced
- Can be given to pregnant and breastfeeding women when indicated
Contraindications:
- Severe allergic reaction to a previous dose or any vaccine component
- Acute gastrointestinal illness or fever (vaccination should be delayed)
Precautions:
- Immunocompromised individuals may have a reduced immune response
- Dukoral: Avoid food and drink 1 hour before and after vaccination
Public Health Impact
Cholera vaccines have become an important tool in cholera control and prevention, particularly in endemic areas and during outbreaks.
Impact on Disease Burden:
- Significant reduction in cholera cases in areas with high vaccination coverage
- Effective in outbreak control when combined with other interventions
- Provides protection to high-risk populations in endemic areas
Cost-Effectiveness:
- OCVs have been shown to be cost-effective in various settings
- Particularly cost-effective when used in targeted vaccination campaigns
Global Stockpile:
- WHO manages a global OCV stockpile for outbreak response and emergency use
- Has facilitated rapid response to cholera outbreaks in multiple countries
Challenges:
- Limited global production capacity
- Cold chain requirements for vaccine storage and distribution
- Need for multiple doses for full protection with most OCVs
- Vaccination alone is not sufficient; must be combined with improvements in water, sanitation, and hygiene
Future Directions:
- Development of more thermostable vaccines
- Research into single-dose vaccines for rapid outbreak response
- Integration of OCV into routine immunization programs in high-risk areas
- Improved surveillance and early warning systems for cholera outbreaks
Global Goals:
The Global Task Force on Cholera Control has set a goal to reduce cholera deaths by 90% by 2030, with OCVs playing a crucial role in this strategy.
Cholera Vaccines
- What is cholera?
An acute diarrheal illness caused by infection with Vibrio cholerae bacteria - How many types of cholera vaccines are currently available?
Two main types: oral cholera vaccines (OCVs) and injectable vaccines - Which oral cholera vaccines are prequalified by the WHO?
Dukoral, Shanchol, Euvichol, and Euvichol-Plus - What is the composition of most oral cholera vaccines?
Killed whole-cell V. cholerae O1, with or without V. cholerae O139 - How is Dukoral different from other oral cholera vaccines?
It contains recombinant cholera toxin B subunit in addition to killed whole cells - What is the recommended dosing schedule for most oral cholera vaccines?
Two doses given 1-6 weeks apart - At what age can oral cholera vaccines be given?
From 1 year of age and older, depending on the specific vaccine - How long does protection last after cholera vaccination?
Typically 3-5 years, with some vaccines providing shorter duration of protection - What is the efficacy of oral cholera vaccines?
About 65-85% protection in the first 6 months after vaccination - Are cholera vaccines recommended for routine use in all countries?
No, they are primarily recommended in cholera-endemic areas or during outbreaks - What is the role of cholera vaccines in outbreak control?
Can be used as part of a comprehensive control strategy, along with water and sanitation improvements - Can cholera vaccines be given to pregnant women?
Yes, the killed oral cholera vaccines are considered safe in pregnancy - What is the global stockpile of oral cholera vaccines used for?
For emergency response to outbreaks and in humanitarian crises - Are cholera vaccines 100% effective in preventing cholera?
No, they provide significant but not complete protection - What are the main advantages of oral cholera vaccines?
Easy to administer, good safety profile, and can induce herd immunity - Can cholera vaccines be used in HIV-positive individuals?
Yes, but the immune response may be lower than in HIV-negative individuals - What is the role of cholera vaccination in travelers?
Recommended for travelers to high-risk areas, especially aid workers - How quickly does protection develop after cholera vaccination?
Usually within 7-10 days after completing the vaccination course - Are there any contraindications for oral cholera vaccines?
Severe allergic reaction to previous dose or any vaccine component - What is the storage requirement for most oral cholera vaccines?
2-8°C (refrigerator temperature), should not be frozen
